Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinze Shen

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cell Death & Disease|November 14, 2024
NINJ1: Bridging lytic cell death and inflammation therapyJinze Shen, Ruixiu Chen, Shiwei Duan
Frontiers in Oncology|April 25, 2022
miR-1908 Dysregulation in Human CancersJinze Shen, Yuchen Wu, Wenjing Ruan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 24, 2022
LINC00963: A potential cancer diagnostic and therapeutic targetZijun Xie, Chenming Zhong, Jinze Shen, et al.
Frontiers in Genetics|April 10, 2024
Unveiling the role of tRNA-derived small RNAs in MAPK signaling pathway: implications for cancer and beyondQurui Wang, Qinyuan Huang, Xiaowei Ying, et al.
Cells|May 14, 2022
LINC00665: An Emerging Biomarker for Cancer Diagnostics and TherapeuticsChenming Zhong, Zijun Xie, Jinze Shen, et al.
Medcomm|May 31, 2023
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studiesJinze Shen, Qurui Wang, Yunan Mao, et al.
Clinical and Translational Medicine|September 7, 2024
RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathyJinze Shen, Jianqiao Shentu, Chenming Zhong, et al.
Oncology Research|June 12, 2023
The tumor suppressor role and ceRNA network of miR-1294 in cancerYunan Mao, Jinze Shen, L I Fang, et al.
Frontiers in Immunology|March 21, 2022
LINC00520: A Potential Diagnostic and Prognostic Biomarker in CancerQiudan Zhang, Jinze Shen, Yuchen Wu, et al.
Bioengineered|October 17, 2022
Aberrant expression of microRNA-4443 (miR-4443) in human diseasesYunan Mao, Jinze Shen, Yuchen Wu, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cell Death & Disease|November 14, 2024
NINJ1: Bridging lytic cell death and inflammation therapyJinze Shen, Ruixiu Chen, Shiwei Duan
Frontiers in Oncology|April 25, 2022
miR-1908 Dysregulation in Human CancersJinze Shen, Yuchen Wu, Wenjing Ruan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 24, 2022
LINC00963: A potential cancer diagnostic and therapeutic targetZijun Xie, Chenming Zhong, Jinze Shen, et al.
Frontiers in Genetics|April 10, 2024
Unveiling the role of tRNA-derived small RNAs in MAPK signaling pathway: implications for cancer and beyondQurui Wang, Qinyuan Huang, Xiaowei Ying, et al.
Cells|May 14, 2022
LINC00665: An Emerging Biomarker for Cancer Diagnostics and TherapeuticsChenming Zhong, Zijun Xie, Jinze Shen, et al.
Medcomm|May 31, 2023
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studiesJinze Shen, Qurui Wang, Yunan Mao, et al.
Clinical and Translational Medicine|September 7, 2024
RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathyJinze Shen, Jianqiao Shentu, Chenming Zhong, et al.
Oncology Research|June 12, 2023
The tumor suppressor role and ceRNA network of miR-1294 in cancerYunan Mao, Jinze Shen, L I Fang, et al.
Frontiers in Immunology|March 21, 2022
LINC00520: A Potential Diagnostic and Prognostic Biomarker in CancerQiudan Zhang, Jinze Shen, Yuchen Wu, et al.
Bioengineered|October 17, 2022
Aberrant expression of microRNA-4443 (miR-4443) in human diseasesYunan Mao, Jinze Shen, Yuchen Wu, et al.
Pageof 3